ABREPTOR Trademark

Trademark Overview


On Thursday, September 19, 2024, a trademark application was filed for ABREPTOR with the United States Patent and Trademark Office. The USPTO has given the ABREPTOR trademark a serial number of 98759550. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 19, 2024. This trademark is owned by Pinetree Therapeutics, Inc.. The ABREPTOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceuticals for others; Research and development of pharmaceuticals for others related to cancer, infectious diseases, and viral related diseases and disorders; Research and development of substances containing multispecific antibodies for degrading receptors and extracellular proteins; Medical research; Medical laboratories; Medical and scientific research in the field of cancer, infectious diseases, and viral related diseases and disorders; Clinical research in the field of cancer, infectious diseases, and viral related diseases and disorders; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy
abreptor

General Information


Serial Number98759550
Word MarkABREPTOR
Filing DateThursday, September 19, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development of pharmaceuticals for others; Research and development of pharmaceuticals for others related to cancer, infectious diseases, and viral related diseases and disorders; Research and development of substances containing multispecific antibodies for degrading receptors and extracellular proteins; Medical research; Medical laboratories; Medical and scientific research in the field of cancer, infectious diseases, and viral related diseases and disorders; Clinical research in the field of cancer, infectious diseases, and viral related diseases and disorders; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 19, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePinetree Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02138

Trademark Events


Event DateEvent Description
Wednesday, October 2, 2024TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, October 2, 2024TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, September 19, 2024NEW APPLICATION ENTERED